cardiovascular system
• greater increase in cross-sectional area following transverse aortic constriction compared to controls
|
• increase in absolute and relative left ventricular mass at 11 months of age but not in mice at 3 or 6 months of age
|
• increase in left ventricular dimension in aged mice
• transverse aortic constriction induced dramatic left ventricular dilation unlike in wild-type controls where this treatment induces left ventricular hypertrophy
|
• extensive fibrosis following transverse aortic constriction
|
• depressed cardiac function in older mice
• however, no detectable cardiac defects in young mice
|
• decrease in ejection fraction and fractional shortening at 11 and 18 months of age but not at 3 or 6 months of age
• dramatic decrease following transverse aortic constriction
|
• transverse aortic constriction induced dramatic left ventricular dilation unlike in wild-type controls where this treatment induces left ventricular hypertrophy
|
• dramatic decrease in cardiac contraction and increase in fibrosis and cardiomyocyte size following transverse aortic constriction
|
homeostasis/metabolism
• transverse aortic constriction induced dramatic left ventricular dilation unlike in wild-type controls where this treatment induces left ventricular hypertrophy
|
• dramatic decrease in cardiac contraction and increase in fibrosis and cardiomyocyte size following transverse aortic constriction
|
muscle
• greater increase in cross-sectional area following transverse aortic constriction compared to controls
|
• decrease in ejection fraction and fractional shortening at 11 and 18 months of age but not at 3 or 6 months of age
• dramatic decrease following transverse aortic constriction
|